April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Spectral-domain Optical Coherence Tomography Features of Regions of Increased Autofluorescence at the Margin of Geographic Atrophy in Patients with Age Related Macular Degeneration
Author Affiliations & Notes
  • Yan Luo
    Doheny Eye Institute, Los Angeles, CA
  • Amirhossein Hariri
    Doheny Eye Institute, Los Angeles, CA
  • Muneeswar G Nittala
    Doheny Eye Institute, Los Angeles, CA
  • Eric C Strauss
    Genentech, Inc., South San Francisco, CA
  • Erin Henry
    Genentech, Inc., South San Francisco, CA
  • Phillip Lai
    Genentech, Inc., South San Francisco, CA
  • Srinivas R Sadda
    Doheny Eye Institute, Los Angeles, CA
    Department of Ophthalmology, University of Southern California, Los Angeles, CA
  • Footnotes
    Commercial Relationships Yan Luo, None; Amirhossein Hariri, None; Muneeswar Nittala, None; Eric Strauss, Genentech (E); Erin Henry, Genentech (E); Phillip Lai, Genentech (E); Srinivas Sadda, Allergan (C), Allergan (F), Carl Zeiss Meditec (C), Carl Zeiss Meditec (F), Genentech (C), Genentech (F), Optos (C), Optos (F), Regeneron (C)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5895. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yan Luo, Amirhossein Hariri, Muneeswar G Nittala, Eric C Strauss, Erin Henry, Phillip Lai, Srinivas R Sadda; Spectral-domain Optical Coherence Tomography Features of Regions of Increased Autofluorescence at the Margin of Geographic Atrophy in Patients with Age Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5895.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To evaluate the spectral-domain optical coherence tomography (SD-OCT) characteristics of the junctional zone corresponding to areas of increased autofluorescence at the margin of geographic atrophy (GA) in patients with age-related macular degeneration (AMD).

 
Methods
 

The MAHALO study (NCT01229215) enrolled 143 eyes of 143 subjects into a Phase Ib/II multicenter, randomized, single-masked, sham-injection controlled clinical trial of the safety, tolerability and evidence of activity of lampalizumab in patients with GA associated with AMD. All patients underwent SD-OCT (Cirrus OCT) and fundus autofluorescence (FAF, Heidelberg HRA or Spectralis) imaging at study entry. Areas of decreased autofluorescence (DAF) corresponding to GA, and areas of increased AF at the margins of the GA were manually segmented at the Doheny Image Reading Center (DIRC) using a standardized grading protocol. At the baseline visit, the first 30 eyes with evidence of increased AF were selected for exploratory analysis of OCT features corresponding to these regions, following manual registration of FAF and OCT data. The thickness of the retinal pigment epithelium (RPE) band on SDOCT in these areas of increased AF as well as in areas of normal background AF were manually segmented and compared.

 
Results
 

No apparent difference in the neural retinal layers was observed in areas of increased AF compared with normal AF. The RPE band, however, was significantly thicker. The mean RPE thickness in areas of increased AF was 40.6 ± 7.69 µm, compared to a mean thickness of 28.8 ± 7.09 µ in normal adjacent areas (P < 0.001). The thickening of the RPE band appeared to be due to the adherence of debris on the RPE surface.

 
Conclusions
 

Regions of increased AF in the junctional zone of GA lesions appear to correspond to thickening of the RPE band on OCT. Longitudinal assessments will be crucial to determine if these OCT findings predict GA progression.

 
Keywords: 550 imaging/image analysis: clinical • 412 age-related macular degeneration • 688 retina  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×